Regeneron Pharmaceuticals Stock Buy Hold or Sell Recommendation

REGN Stock  USD 962.49  3.81  0.39%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Regeneron Pharmaceuticals is 'Strong Hold'. Macroaxis provides Regeneron Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding REGN positions. The advice algorithm takes into account all of Regeneron Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Regeneron Pharmaceuticals' buy or sell advice are summarized below:
Real Value
692.99
Target Price
912.52
Hype Value
962.49
Market Value
962.49
Naive Value
962.39
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Regeneron Pharmaceuticals given historical horizon and risk tolerance towards Regeneron Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Regeneron Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Regeneron Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
In addition, we conduct extensive research on individual companies such as Regeneron and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Execute Regeneron Pharmaceuticals Buy or Sell Advice

The Regeneron recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Regeneron Pharmaceuticals. Macroaxis does not own or have any residual interests in Regeneron Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Regeneron Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Regeneron PharmaceuticalsBuy Regeneron Pharmaceuticals
Strong Hold

Market Performance

GoodDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Regeneron Pharmaceuticals has a Risk Adjusted Performance of 0.1161, Jensen Alpha of 0.1179, Total Risk Alpha of (0.03), Sortino Ratio of 0.0723 and Treynor Ratio of 0.3315
Macroaxis provides advice on Regeneron Pharmaceuticals to complement and cross-verify current analyst consensus on Regeneron Pharmaceuticals. Our recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Regeneron Pharmaceuticals is not overpriced, please check all Regeneron Pharmaceuticals fundamentals, including its debt to equity, market capitalization, and the relationship between the ebitda and earnings per share . Given that Regeneron Pharmaceuticals has a price to earning of 15.51 X, we recommend you to check out Regeneron Pharmaceuticals market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Regeneron Pharmaceuticals Trading Alerts and Improvement Suggestions

Regeneron Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 89.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Latest Global Cancer Immunotherapy Market SizeShare Worth USD 314.4 Billion by 2032 at a 7.2 percent CAGR Custom Market Insights

Regeneron Pharmaceuticals Returns Distribution Density

The distribution of Regeneron Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Regeneron Pharmaceuticals' future price movements. The chart of the probability distribution of Regeneron Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Regeneron Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Regeneron Pharmaceuticals returns is essential to provide solid investment advice for Regeneron Pharmaceuticals.
Mean Return
0.20
Value At Risk
-1.18
Potential Upside
1.73
Standard Deviation
0.99
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Regeneron Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Regeneron Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Regeneron Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regeneron Pharmaceuticals backward and forwards among themselves. Regeneron Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Regeneron Pharmaceuticals' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Wellington Management Company Llp2023-12-31
1.1 M
Northern Trust Corp2023-09-30
1.1 M
Norges Bank2023-12-31
1.1 M
Morgan Stanley - Brokerage Accounts2023-09-30
971 K
Bank Of New York Mellon Corp2023-09-30
967.4 K
American Century Companies Inc2023-12-31
931.3 K
Bank Of America Corp2023-09-30
836.9 K
Legal & General Group Plc2023-09-30
820.2 K
Amvescap Plc.2023-09-30
743.3 K
Fmr Inc2023-09-30
9.8 M
Blackrock Inc2023-09-30
8.9 M
Note, although Regeneron Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Regeneron Pharmaceuticals Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash150.1M577M690.8M221.3M(381.6M)(362.5M)
Free Cash Flow2.0B2.0B6.5B4.4B3.7B3.9B
Depreciation210.3M235.9M286.2M341.4M421M442.1M
Other Non Cash Items(29.3M)(135M)181.7M599.8M266.3M279.6M
Capital Expenditures429.6M614.6M551.9M590.1M926.4M972.7M
Net Income2.1B3.5B8.1B4.3B4.0B4.2B
End Period Cash Flow1.6B2.2B2.9B3.1B2.7B2.9B
Change To Inventory(335.5M)(529.4M)(494.3M)(696.5M)(271.7M)(258.1M)
Investments(1.6B)544M(4.8B)(1.9B)(5.0B)(4.7B)
Change To Netincome314.2M(895.1M)(994M)676.5M608.9M639.3M

Regeneron Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Regeneron Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Regeneron Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Regeneron stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.12
β
Beta against NYSE Composite0.57
σ
Overall volatility
0.95
Ir
Information ratio 0.06

Regeneron Pharmaceuticals Volatility Alert

Regeneron Pharmaceuticals has low volatility with Treynor Ratio of 0.33, Maximum Drawdown of 5.22 and kurtosis of 0.76. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Regeneron Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Regeneron Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Regeneron Pharmaceuticals Implied Volatility

Regeneron Pharmaceuticals' implied volatility exposes the market's sentiment of Regeneron Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regeneron Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regeneron Pharmaceuticals stock will not fluctuate a lot when Regeneron Pharmaceuticals' options are near their expiration.

Regeneron Pharmaceuticals Fundamentals Vs Peers

Comparing Regeneron Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Regeneron Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Regeneron Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Regeneron Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Regeneron Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Regeneron Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Regeneron Pharmaceuticals to competition
FundamentalsRegeneron PharmaceuticalsPeer Average
Return On Equity0.16-0.31
Return On Asset0.0849-0.14
Profit Margin0.30 %(1.27) %
Operating Margin0.29 %(5.51) %
Current Valuation97.99 B16.62 B
Shares Outstanding107.94 M571.82 M
Shares Owned By Insiders2.58 %10.09 %
Shares Owned By Institutions89.10 %39.21 %
Number Of Shares Shorted1.39 M4.71 M
Price To Earning15.51 X28.72 X
Price To Book4.09 X9.51 X
Price To Sales8.04 X11.42 X
Revenue13.12 B9.43 B
Gross Profit7.02 B27.38 B
EBITDA4.05 B3.9 B
Net Income3.95 B570.98 M
Cash And Equivalents7.02 B2.7 B
Cash Per Share65.75 X5.01 X
Total Debt2.7 B5.32 B
Debt To Equity0.13 %48.70 %
Current Ratio5.36 X2.16 X
Book Value Per Share242.47 X1.93 K
Cash Flow From Operations4.59 B971.22 M
Short Ratio2.99 X4.00 X
Earnings Per Share34.81 X3.12 X
Price To Earnings To Growth1.56 X4.89 X
Target Price1041.59
Number Of Employees13.45 K18.84 K
Beta0.11-0.15
Market Capitalization105.41 B19.03 B
Total Asset33.08 B29.47 B
Retained Earnings27.26 B9.33 B
Working Capital16.06 B1.48 B
Note: Disposition of tradable shares by Andrew Murphy of Regeneron Pharmaceuticals at 962.87 subject to Rule 16b-3 [view details]

Regeneron Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Regeneron . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Regeneron Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Regeneron Pharmaceuticals? Buying financial instruments such as Regeneron Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Total Current Liabilities3.5B3.8B3.4B3.6B
Total Assets25.4B29.2B33.1B34.7B

Use Investing Ideas to Build Portfolios

In addition to having Regeneron Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Municipals ETFs Thematic Idea Now

Broad Municipals ETFs
Broad Municipals ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Regeneron Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Correlations
Find global opportunities by holding instruments from different markets
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.81
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.